These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 31081117)
41. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer. Skírnisdóttir I; Seidal T Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012 [TBL] [Abstract][Full Text] [Related]
42. Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Hermens M; van Altena AM; Nieboer TE; Schoot BC; van Vliet HAAM; Siebers AG; Bekkers RLM Am J Obstet Gynecol; 2020 Jul; 223(1):107.e1-107.e11. PubMed ID: 31981507 [TBL] [Abstract][Full Text] [Related]
43. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis. Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289 [TBL] [Abstract][Full Text] [Related]
44. Endometrioid adenocarcinoma of the ovary and endometriosis. Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279 [TBL] [Abstract][Full Text] [Related]
45. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
46. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis. Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241 [TBL] [Abstract][Full Text] [Related]
47. Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before. Yang ST; Chang WH; Lee NR; Lai WA; Shen SH; Lee WL; Wang PH Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1112-1115. PubMed ID: 34794748 [TBL] [Abstract][Full Text] [Related]
49. Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Dzatic-Smiljkovic O; Vasiljevic M; Djukic M; Vugdelic R; Vugdelic J Clin Exp Obstet Gynecol; 2011; 38(4):394-8. PubMed ID: 22268283 [TBL] [Abstract][Full Text] [Related]
50. Histologic Subtypes in Endometriosis-Associated Ovarian Cancer and Ovarian Cancer Arising in Endometriosis: A Systematic Review and Meta-Analysis. Chiaffarino F; Cipriani S; Ricci E; Esposito G; Parazzini F; Vercellini P Reprod Sci; 2024 Jun; 31(6):1642-1650. PubMed ID: 38438776 [TBL] [Abstract][Full Text] [Related]
51. Demographic, Clinical, and Prognostic Factors of Ovarian Clear Cell Adenocarcinomas According to Endometriosis Status. Schnack TH; Høgdall E; Thomsen LN; Høgdall C Int J Gynecol Cancer; 2017 Nov; 27(9):1804-1812. PubMed ID: 28976447 [TBL] [Abstract][Full Text] [Related]
52. Prognostic analysis of ovarian cancer associated with endometriosis. Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136 [TBL] [Abstract][Full Text] [Related]
53. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging. Zhang X; Li M; Tang Z; Li X; Song T Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252 [TBL] [Abstract][Full Text] [Related]
54. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. McMeekin DS; Burger RA; Manetta A; DiSaia P; Berman ML Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621 [TBL] [Abstract][Full Text] [Related]
55. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma. Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of endometriosis in epithelial ovarian cancer. Analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality. Machado-Linde F; Sánchez-Ferrer ML; Cascales P; Torroba A; Orozco R; Silva Sánchez Y; Nieto A; Fiol G Eur J Gynaecol Oncol; 2015; 36(1):21-4. PubMed ID: 25872329 [TBL] [Abstract][Full Text] [Related]
57. Prevalence of endometriosis in ovarian cancer. Yoshikawa H; Jimbo H; Okada S; Matsumoto K; Onda T; Yasugi T; Taketani Y Gynecol Obstet Invest; 2000; 50 Suppl 1():11-7. PubMed ID: 11093056 [TBL] [Abstract][Full Text] [Related]
58. Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients. Mizuno M; Kajiyama H; Shibata K; Mizuno K; Kawai M; Nagasaka T; Kikkawa F Br J Cancer; 2015 Apr; 112(8):1376-83. PubMed ID: 25867257 [TBL] [Abstract][Full Text] [Related]
59. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival? Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487 [TBL] [Abstract][Full Text] [Related]
60. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]